Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Galectin Therapeutics Inc (GALT)  
$3.45 0.05 (1.43%) as of 4:30 Fri 4/26


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 57,080,000
Market Cap: 196.93(M)
Last Volume: 97,895 Avg Vol: 97,622
52 Week Range: $1.32 - $4.2
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    : 4.5
Insider 6 Months    : 5.2
Insider 3/6 Months : 9.9
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 3,500 4,000 5,598 32,898
Total Buy Value $10,840 $11,733 $14,587 $57,671
Total People Bought 2 3 3 5
Total Buy Transactions 2 3 4 11
Total Shares Sold 25,000 25,000 25,000 45,000
Total Sell Value $76,500 $76,500 $76,500 $118,240
Total People Sold 1 1 1 2
Total Sell Transactions 2 2 2 4
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 516
  Page 10 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-06-05 4 AS $5.16 $51,183 D/D (9,924) 53,914     -
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-06-05 4 OE $0.87 $16,797 D/D 9,924 69,338     -
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-06-04 4 AS $5.15 $56,173 D/D (10,907) 53,914     -
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-06-04 4 OE $0.87 $17,464 D/D 10,907 64,821     -
   Czirr James C Director   –       •      –    2018-06-04 4 S $5.13 $41,517 I/I (8,093) 3,119,786     -
   10x Capital Management, Llc 10% Owner   –       –       •   2018-06-04 4 S $5.13 $41,517 I/I (8,093) 3,119,786     -
   Czirr James C Director   –       •      –    2018-06-01 4 S $5.12 $214,564 I/I (41,907) 3,161,693     -
   10x Capital Management, Llc 10% Owner   –       –       •   2018-06-01 4 S $5.12 $214,564 I/I (41,907) 3,161,693     -
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-06-01 4 AS $5.10 $352,920 D/D (69,200) 53,914     -
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-06-01 4 OE $0.87 $73,979 D/D 69,200 123,114     -
   Callicutt Jack W Chief Financial Officer   •       –      –    2018-05-31 4 AS $5.00 $233,255 D/D (46,651) 1,260     -
   Callicutt Jack W Chief Financial Officer   •       –      –    2018-05-31 4 OE $0.87 $40,586 D/D 46,651 47,911     -
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-05-31 4 AS $5.00 $250,000 D/D (50,000) 53,914     -
   Shlevin Harold H. Chief Operating Officer   •       –      –    2018-05-31 4 OE $2.32 $116,000 D/D 50,000 103,914     -
   Zucconi Theodore Daniel Director   –       •      –    2018-04-16 4 S $3.58 $14,320 D/D (4,000) 1,083     -
   Zucconi Theodore Daniel Director   –       •      –    2018-04-16 4 OE $0.89 $3,560 D/D 4,000 5,083     -
   Callicutt Jack W Chief Financial Officer   •       –      –    2018-04-04 4 AS $5.00 $16,745 D/D (3,349) 1,260     -
   Callicutt Jack W Chief Financial Officer   •       –      –    2018-04-04 4 OE $0.87 $2,914 D/D 3,349 4,609     -
   Freeman Kevin D Director   –       •      –    2018-02-01 4 B $4.10 $8,191 I/I 2,000 16,000 2.1     -
   Czirr James C Director   –       •      –    2018-01-26 4 S $5.35 $210,255 I/I (39,300) 3,120,984     -
   10x Capital Management, Llc 10% Owner   –       –       •   2018-01-26 4 S $5.35 $210,255 I/I (39,300) 3,120,984     -
   Czirr James C Director   –       •      –    2018-01-25 4 S $5.45 $1,118,035 I/I (205,144) 3,160,284     -
   10x Capital Management, Llc 10% Owner   –       –       •   2018-01-25 4 S $5.45 $1,118,035 I/I (205,144) 3,160,284     -
   Uihlein Richard E Director   –       •       •   2017-12-14 4 A $2.39 $34,999 D/D 14,644 2,524,553     -
   Lewis Joel Director   –       •      –    2017-12-14 4 A $2.39 $55,001 D/D 23,013 50,880     -
  516 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us